Climb Bio, Inc. (CLYM) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Climb Bio, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -4.53x | -1.17x | -6.02x | -4.55x | -2.02x | -4.42x |
| P/B Ratio | 1.69x | 0.41x | 1.96x | 1.60x | 0.57x | 4.23x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 15.16x | 31.41x | 38.92x | 22.04x | 24.58x | 7.18x |
| Quick Ratio | 15.16x | 31.41x | 38.92x | 22.04x | 24.58x | 7.18x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..